| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2764808 | Journal of Critical Care | 2014 | 6 Pages |
Abstract
Although the median daily drug cost for an adult critically ill patient was low, this cost significantly escalated with patient acuity and hematologic malignancy. A reference method has been designed for an in-depth evaluation of daily drug cost that could be used to compare expenditure in other units.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Sumayah MPharm, Ian BPharm, MSc, FFRPS, Graham BPharm, MSc (Clinical Pharmacy), PhD, Rob MRPharmS, DipClinPharm, DHC(Pharm), FFRPS,